Mebocaína Intensive Spray

Flurbiprofen, the active ingredient in Mebocaína Intensive Spray, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oromucosal spray for local oral use. It is employed to relieve mild to moderate pain and to reduce inflammation of the oral mucosa, such as sore throat, oral ulceration, and dental discomfort.

GNH USA supplies Mebocaína Intensive Spray as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across all markets through rigorous manufacturing standards and reliable delivery.

Flurbiprofen acts as a topical NSAID to manage pain and inflammation in the oral cavity.

- Sore throat: provides temporary relief of pain and reduces inflammation of the throat lining. - Oral mucosal inflammation: decreases swelling and discomfort associated with conditions such as aphthous ulcers. - Mild to moderate dental pain: alleviates pain related to minor dental procedures or gum irritation. - Post‑extraction discomfort: helps soothe pain and inflammation after tooth removal. - Gingivitis‑associated pain: reduces discomfort and inflammatory symptoms in inflamed gums.

Flurbiprofen may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Burning sensation: mild burning at the site of application. - Taste alteration: temporary metallic or bitter taste in the mouth. - Dry mouth: transient reduction in salivary flow. - Mild irritation: slight redness or itching of the oral mucosa.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or difficulty breathing indicating possible anaphylaxis. - Gastrointestinal ulceration: rare systemic effect leading to stomach or intestinal ulcers. - Renal impairment: uncommon worsening of kidney function, especially in predisposed patients. - Hepatic dysfunction: rare elevation of liver enzymes or hepatitis.

When using Mebocaína Intensive Spray, consider the following precautions to ensure safe and effective use. - Contraindication: avoid in patients with known hypersensitivity to flurbiprofen or other NSAIDs. - Gastrointestinal risk: use cautiously in individuals with a history of ulcers or bleeding. - Cardiovascular caution: assess risk in patients with hypertension or heart disease. - Renal caution: monitor kidney function in patients with renal impairment. - Pregnancy and lactation: safety not established; use only if clearly needed. - Store at room temperature: keep below 25 °C, protect from moisture and direct sunlight in the original container.

Flurbiprofen can interact with several medicines; awareness of these interactions helps prevent adverse effects.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Corticosteroids: additive risk of ulceration.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function. - Diuretics: potential for decreased effectiveness and renal effects. - Lithium: NSAIDs can raise lithium levels, requiring monitoring.